Evidence supporting the use of: Bromelain
For the health condition: Blood Clots (prevention of)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Bromelain, an enzyme complex derived from pineapples, has been investigated for its potential anticoagulant and antithrombotic effects. Several in vitro and animal studies have shown that bromelain can decrease platelet aggregation and fibrin formation, which are key factors in the development of blood clots. Additionally, some research suggests that bromelain may stimulate the conversion of plasminogen to plasmin, enhancing fibrinolysis (the breakdown of clots). Small human studies and case reports have indicated that bromelain supplementation may help reduce the risk of thrombosis, particularly in situations of increased clot risk, such as post-surgical recovery or chronic inflammation. However, the evidence in humans remains limited and is not as robust as for standard anticoagulant medications. Most clinical trials are small in scale, and there is a lack of large randomized controlled trials to firmly establish its efficacy and safety for blood clot prevention. Nonetheless, bromelain is sometimes used as a complementary approach in naturopathic and integrative medicine settings for its potential circulatory benefits. While the mechanistic data and preliminary studies are promising, bromelain should not be relied upon as a primary therapy for clot prevention, especially in high-risk individuals. Anyone considering its use for this purpose should consult with a healthcare provider due to possible interactions with anticoagulant drugs and the risk of bleeding.

More about bromelain
More about Blood Clots (prevention of)